- Home
- AES vs RVTY Comparison
AES vs RVTY Comparison
Compare AES & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AES | RVTY |
|---|---|---|
| Founded | 1981 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 11.8B |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AES | RVTY |
|---|---|---|
| Price | $14.03 | $84.75 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 15 |
| Target Price | $15.57 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 17.6M | 980.7K |
| Earning Date | 03-02-2026 | 04-27-2026 |
| Dividend Yield | ★ 5.03% | 0.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.26 | ★ 2.07 |
| Revenue | ★ $12,233,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $6.29 | $6.34 |
| Revenue Next Year | $4.85 | $5.10 |
| P/E Ratio | ★ $11.12 | $40.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.46 | $81.36 |
| 52 Week High | $17.65 | $118.30 |
Technical Indicators
Market Signals| Indicator | AES | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 35.38 |
| Support Level | $13.98 | $83.11 |
| Resistance Level | $14.20 | $94.75 |
| Average True Range (ATR) | 0.07 | 2.77 |
| MACD | 0.01 | 0.22 |
| Stochastic Oscillator | 14.81 | 20.23 |
Price Performance
Historical ComparisonAbout AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.